CN1586574A - Medicine for reducing blood fat - Google Patents
Medicine for reducing blood fat Download PDFInfo
- Publication number
- CN1586574A CN1586574A CN 200410069151 CN200410069151A CN1586574A CN 1586574 A CN1586574 A CN 1586574A CN 200410069151 CN200410069151 CN 200410069151 CN 200410069151 A CN200410069151 A CN 200410069151A CN 1586574 A CN1586574 A CN 1586574A
- Authority
- CN
- China
- Prior art keywords
- gram
- rhizoma
- radix
- medicine
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 24
- 210000004369 blood Anatomy 0.000 title claims abstract description 24
- 239000003814 drug Substances 0.000 title claims abstract description 17
- 229940079593 drug Drugs 0.000 title description 4
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 5
- 241000180649 Panax notoginseng Species 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 231100000252 nontoxic Toxicity 0.000 abstract description 13
- 230000003000 nontoxic effect Effects 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 9
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 7
- 235000008216 herbs Nutrition 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 230000004089 microcirculation Effects 0.000 abstract description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 210000000748 cardiovascular system Anatomy 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 201000005665 thrombophilia Diseases 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 241000201295 Euphrasia Species 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000009290 primary effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The medicine for reducing blood fat is characterized by being a medicament prepared from the following raw materials in parts by weight: 5-20 g of pseudo-ginseng, 10-60 g of hawthorn, 10-80 g of rhizoma alismatis, 5-30 g of cassia seed, 10-50 g of giant knotweed, 10-40 g of fleece-flower root, 10-40 g of salvia miltiorrhiza, 5-20 g of red paeony root, 10-40 g of rhizoma polygonati, 10-30 g of radix scrophulariae, 10-40 g of medlar and 10-40 g of rhizoma drynariae. The Chinese medicinal composition is prepared from Chinese medicinal herbs which are nontoxic and harmless to human bodies and have no side effect, can be directly taken without decoction, can better absorb effective lipid-lowering components in the Chinese medicinal herbs, can be directly applied to the cardiovascular system, has good treatment effect, can improve the hypercoagulability of blood, dredge microcirculation, enhance the immunity of organisms and relieve the occurrence of hyperlipidemia complications, and is very convenient to take and carry.
Description
Technical field:
The present invention relates to the blood lipid-lowering medicine of a kind of effectively triglyceride reducing and cholesterol, being specially a kind of is the Chinese patent medicine that raw material is made with the Chinese herbal medicine.
Background technology:
Along with improving constantly of human living standard, hypertension, hyperlipidemia class disease are on the increase, serious harm the people's lives health.Because blood fat increases, and can cause the body fat mass in human body metabolism disorder, causes the rising of blood viscosity, brings a series of cardiovascular and cerebrovascular disease thus.The drug main of blood fat reducing in the market will be that primary and secondary effect is big with Western medicine, though the preparation that share of some Chinese and western drugs is arranged, as " Radix Oenotherae erythrosepalae oil ", curative effect is not obvious, and certain untoward reaction is also arranged.
Summary of the invention:
Technical problem solved by the invention is to overcome above-mentioned prior art defective, and a kind of good effect, instant effect, taking convenience pure Chinese medicinal preparation without any side effects are provided.
Technical problem of the present invention is to solve by following technical scheme.It is characterized in that it is the medicament of being made by the following weight proportion raw material: Radix Notoginseng 5-20 gram, Fructus Crataegi 10-60 gram, Rhizoma Alismatis 10-80 gram, Semen Cassiae 5-30 gram, Rhizoma Polygoni Cuspidati 10-50 gram, Radix Polygoni Multiflori 10-40 gram, Radix Salviae Miltiorrhizae 10-40 gram, Radix Paeoniae Rubra 5-20 gram, Rhizoma Polygonati 10-40 gram, Radix Scrophulariae 10-30 gram, Fructus Lycii 10-40 gram, Rhizoma Drynariae 10-40 gram cleans the back levigation with above-mentioned raw materials, and the reuse hydromel is modulated into pill and gets final product.
The present invention all select for use to human body nontoxic, harmless, without any side effects among medical herbs be raw material, need not decoct directly and take, can absorb effective blood fat reducing composition in the Chinese herbal medicine preferably, direct drug injection is in cardiovascular, and the treatment good effect can be improved high blood coagulation state, the mediation microcirculation, the enhancing body ability of exempting from service is alleviated the generation of hyperlipidemia complication, and it is all very convenient to take and carry.
The specific embodiment:
Chinese medicine thinks that the pathogenesis of hyperlipidemia is " blood stasis due to qi deficiency ".Human body is an organic whole that QI and blood is interdependent, internal organs are relevant, and the pathological changes of hyperlipidemia can have influence on the function of whole heart and brain.Scientific practice proves that the Metabolic disorder of lipid (blood fat is accumulated) is arteriosclerotic sign, and hyperlipidemia is the promoting factor of coronary heart disease.The present invention is directed to high fat of blood and complication pathogeny, with " benefiting QI for activating blood circulation YIN nourishing blood stasis dispelling " is aim, selects activating blood circulation to dissipate blood stasis, air making-up and spleen enlivening, dispersing the stagnated live-QI to relieve the stagnation of QI, tonifying the kidney to consolidate the essence, the mode of conditioning comprehensively for use, and making brings about the desired sensation does not emptyly hinder, blood is brought about the desired sensation and is not stagnated, to reach good lipid-lowering effect.It is concrete, and to implement be that it comprises Radix Notoginseng 5-20 gram, Fructus Crataegi 10-60 gram with the following materials of weight proportions pill made of formulation method routinely, Rhizoma Alismatis 10-80 gram, Semen Cassiae 5-30 gram, Rhizoma Polygoni Cuspidati 10-50 gram, Radix Polygoni Multiflori 10-40 gram, Radix Salviae Miltiorrhizae 10-40 gram, Radix Paeoniae Rubra 5-20 gram, Rhizoma Polygonati 10-40 gram, Radix Scrophulariae 10-30 gram, Fructus Lycii 10-40 gram, Rhizoma Drynariae 10-40 gram.In the said medicine compatibility, the Radix Notoginseng sweet in the mouth, little hardship, nontoxic, removing stasis to stop bleeding, the analgesic therapy of invigorating blood circulation is with controlling inside and outside various hemorrhage, Blood stasis; Fructus Crataegi sour in the mouth, sweet, nontoxic, but promoting digestion and removing stagnation, spleen invigorating, blood circulation promoting and blood stasis dispelling has good curative effect to hyperlipidemia; Rhizoma Alismatis sweet in the mouth, cold, nontoxic can be supported the five internal organs, physical strength profiting, and tonifying deficiency, sharp wing expels the heat-evil, and promoting diuresis by dispersing lung-QI removes anemofrigid-damp arthralgia, cholesterol reducing, blood pressure lowering; Semen Cassiae salty in the mouth, flat, nontoxic, but liver heat removing, kidney tonifying make eye bright the suppressing the hyperactive liver blood pressure lowering; Rhizoma Polygoni Cuspidati bitter in the mouth, cold, nontoxic, the heat clearing away of can invigorating blood circulation is pounced on damage congestion, removing toxic substances and promoting subsidence of swelling; Radix Polygoni Multiflori bitter in the mouth, puckery, tepor is nontoxic, but subduing inflammation is only pained, beneficial vim and vigour, and long muscles and bones, the modern times are used for arteriosclerosis, diseases such as hypercholesterolemia, evidence is evident in efficacy; Radix Salviae Miltiorrhizae bitter in the mouth, suffering, cold, nontoxic, the sedate of can reposing, the tonneau GUAN-pulse is gone trusted subordinate's pathogen, and cold and heat gather, but blood circulation promoting and blood stasis dispelling, tonify deficiency QI invigorating, logical percardium; The Radix Paeoniae Rubra bitter in the mouth, nontoxic, can clear and coherent blood vessels, disappear to mend and decrease congestion, the five internal organs by force, the kidney invigorating gas, soothing the liver strongly fragrant, clearing away heat and cooling blood; Rhizoma Polygonati sweet in the mouth, flat, nontoxic, but invigorating the spleen and replenishing QI helps muscles and bones, strengthening the spleen stomach, profit cardiopulmonary, tonifying the kidney to consolidate the essence; The Radix Scrophulariae bitter in the mouth, be slightly cold, nontoxic, but the reinforcing YIN-essence the kidney invigorating and essence nourishing, tonify deficiency makes eye bright, clearing away heat and cooling blood, YIN nourishing detoxifcation; Fructus Lycii bitter in the mouth, cold can hard muscles and bones, removes asthenia, mends vital essence, and the nourishing kidney lung moistening makes eye bright, and controls interior-heat and quenches one's thirst, blood deficiency and yellow complexion; Rhizoma Drynariae bitter in the mouth, temperature, nontoxic, but the removing blood stasis hemostasis, modern medicine is used for the accelerate blood circulation.
Embodiment:
Get Radix Notoginseng 15 grams, Fructus Crataegi 35 grams, Rhizoma Alismatis 45 grams, Semen Cassiae 20 grams, Rhizoma Polygoni Cuspidati 30 grams, the Radix Polygoni Multiflori 25 grams, Radix Salviae Miltiorrhizae 25 grams, Radix Paeoniae Rubra 15 grams, Rhizoma Polygonati 25 grams, Radix Scrophulariae 20 grams, Fructus Lycii 25 gram, Rhizoma Drynariae 25 grams, after said medicine cleaned, pulverize was called in hydromel then and is made pill and get final product.
Claims (1)
1, a kind of medicine of blood fat reducing is characterized in that it is the medicament of being made by the following weight proportion raw material:
Radix Notoginseng 5-20 gram, Fructus Crataegi 10-60 gram, Rhizoma Alismatis 10-80 gram, Semen Cassiae 5-30 gram, Rhizoma Polygoni Cuspidati 10-50 gram, Radix Polygoni Multiflori 10-40 gram, Radix Salviae Miltiorrhizae 10-40 gram, Radix Paeoniae Rubra 5-20 gram, Rhizoma Polygonati 10-40 gram, Radix Scrophulariae 10-30 gram, Fructus Lycii 10-40 gram, Rhizoma Drynariae 10-40 gram.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410069151 CN1586574A (en) | 2004-07-07 | 2004-07-07 | Medicine for reducing blood fat |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410069151 CN1586574A (en) | 2004-07-07 | 2004-07-07 | Medicine for reducing blood fat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1586574A true CN1586574A (en) | 2005-03-02 |
Family
ID=34604283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410069151 Pending CN1586574A (en) | 2004-07-07 | 2004-07-07 | Medicine for reducing blood fat |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1586574A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101987188A (en) * | 2010-11-19 | 2011-03-23 | 何明华 | Biological Chinese patent drug for preventing and treating hyperlipoidemia |
| CN101785812B (en) * | 2009-01-24 | 2012-01-04 | 上海市普陀区中心医院 | Compound preparation for fatty liver treatment |
| CN101239151B (en) * | 2008-03-07 | 2012-02-29 | 谢兴胜 | Chinese medicine for preventing and controlling cardiovascular and cerebrovascular diseases and preparation method thereof |
| CN104324134A (en) * | 2014-10-30 | 2015-02-04 | 梁小琼 | Traditional Chinese medicine composition for improving microcirculation and preparation method of traditional Chinese medicine composition |
| CN104921244A (en) * | 2015-07-05 | 2015-09-23 | 青岛浩大海洋保健食品有限公司 | Astaxanthin health beverage with blood lipid regulation function |
| CN105031243A (en) * | 2015-08-12 | 2015-11-11 | 任德旺 | Lipid-regulating and liver-clearing Chinese herba preparation |
| CN105125873A (en) * | 2015-10-03 | 2015-12-09 | 南京多宝生物科技有限公司 | Pharmaceutical preparation for treating hyperlipidemia |
| CN105497812A (en) * | 2016-01-23 | 2016-04-20 | 李汶峰 | Traditional Chinese medicine for treating hyperlipaemia |
-
2004
- 2004-07-07 CN CN 200410069151 patent/CN1586574A/en active Pending
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101239151B (en) * | 2008-03-07 | 2012-02-29 | 谢兴胜 | Chinese medicine for preventing and controlling cardiovascular and cerebrovascular diseases and preparation method thereof |
| CN101785812B (en) * | 2009-01-24 | 2012-01-04 | 上海市普陀区中心医院 | Compound preparation for fatty liver treatment |
| CN101987188A (en) * | 2010-11-19 | 2011-03-23 | 何明华 | Biological Chinese patent drug for preventing and treating hyperlipoidemia |
| CN101987188B (en) * | 2010-11-19 | 2012-05-30 | 何明华 | Biological Chinese patent drug for preventing and treating hyperlipoidemia |
| CN104324134A (en) * | 2014-10-30 | 2015-02-04 | 梁小琼 | Traditional Chinese medicine composition for improving microcirculation and preparation method of traditional Chinese medicine composition |
| CN104921244A (en) * | 2015-07-05 | 2015-09-23 | 青岛浩大海洋保健食品有限公司 | Astaxanthin health beverage with blood lipid regulation function |
| CN105031243A (en) * | 2015-08-12 | 2015-11-11 | 任德旺 | Lipid-regulating and liver-clearing Chinese herba preparation |
| CN105031243B (en) * | 2015-08-12 | 2018-09-18 | 任德旺 | A kind of tune fat clearing liver Chinese medicine preparation |
| CN105125873A (en) * | 2015-10-03 | 2015-12-09 | 南京多宝生物科技有限公司 | Pharmaceutical preparation for treating hyperlipidemia |
| CN105497812A (en) * | 2016-01-23 | 2016-04-20 | 李汶峰 | Traditional Chinese medicine for treating hyperlipaemia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103156972B (en) | Traditional Chinese medicine combination for treating fracture, hairline fracture and traumatic injury | |
| CN1895557A (en) | Chinese-medicinal herb for treating hypertension, high-blood-fat and hyperglycosemia | |
| CN102166317B (en) | Traditional Chinese medicine combination for curing metrorrhagia and metrostaxis | |
| CN103330805A (en) | Traditional Chinese medicine composition for treating menorrhagia | |
| CN102872411A (en) | Traditional Chinese medicine composition for treating jaundice | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN1586574A (en) | Medicine for reducing blood fat | |
| CN104173565B (en) | A kind of Chinese medicine composition treating menoxenia | |
| CN101239151B (en) | Chinese medicine for preventing and controlling cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN101468148B (en) | Chinese medicinal composition for treating coronary heart disease and cerebral arteriosclerosis, and method for preparing the same | |
| CN102430105B (en) | Traditional Chinese medicine composite for treating chronic gastritis | |
| CN1663415A (en) | Siberian solomonseal rhizome medicinal tea and its preparation | |
| CN101757312A (en) | Chinese medicine preparation for treating thrombocytopenia | |
| CN102657795A (en) | Traditional Chinese medicine preparation for promoting postoperative incision healing | |
| CN101797369B (en) | Traditional Chinese medicinal composition for treating gastric atony | |
| CN101239134B (en) | Speckle-removing medicinal composition | |
| CN102416146B (en) | Chinese medicinal composition for treating amenorrhea | |
| CN101376018A (en) | Chinese medicine for treating chronic cholangitis and angiocholitis | |
| CN103212044B (en) | Traditional Chinese medicine composition for treating cardiovascular diseases | |
| CN105749173A (en) | Drug for treating cirrhosis and preparation method thereof | |
| CN102139083A (en) | Formula of medicament for treating cholecystitis and urolithiasis | |
| CN101554421A (en) | Traditional Chinese medicine formula for curing acute appendicitis | |
| CN104306872A (en) | Traditional Chinese medicine for treating uterine fibroid | |
| CN103285130B (en) | Chinese medicine composition for liver cancer treatment and preparing method thereof | |
| CN102973762B (en) | Traditional Chinese medicine prescription used for treating lumbago caused by essence and blood loss of liver and kidney |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |